Elías Campo

Sobre mí

Publicaciones destacadas

• Molecular map of chronic lymphocytic leukemia and its impact on outcome

  Autores:

  Knisbacher, BA; Lin, ZA; Hahn, CK; Nadeu, F; Duran-Ferrer, M;

  (...)

  Puente, XS; Stilgenbauer, S; Wu, CJ; Campo, E; Getz, G.

  Ver listado completo de autores

  Referencia: Nature Genetics 2022.

• The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee

  Autores:

  Campo, E; Jaffe, ES; Cook, JR; Quintanilla-Martinez, L; Swerdlow, SH;

  (...)

  Zinzani, PL; Dreyling, M; Scott, DW; Winter, JN; Zelenetz, A.

  Ver listado completo de autores

  Referencia: Blood 2022.

• Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

  Autores:

  Nadeu, Ferran; Royo, Romina; Massoni-Badosa, Ramon; Garcia-Torre, Beatriz; Duran-Ferrer, Marti;

  (...)

  Capella-Gutierrez, Salvador; Li Gelp, Josep; Lopez-Bigas, Niiria; Garcia-Roves, Pablo M; Martin-Subero, Jose, I.

  Ver listado completo de autores

  Referencia: Nature Medicine 2022.

• IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

  Autores:

  Nadeu, F; Royo, R; Clot, G; Duran-Ferrer, M; Navarro, A;

  (...)

  Jares, P; Puente, XS; Martín-Subero, JI; Delgado, J; Campo, E.

  Ver listado completo de autores

  Referencia: Blood 2021.

• Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes

  Autores:

  Nadeu, Ferran; Martin-Garcia, David; Clot, Guillem; Diaz-Navarro, Ander; Duran-Ferrer, Marti;

  (...)

  Kuppers, Ralf; Martin-Subero, Jose, I; Puente, Xose S; Bea, Silvia; Campo, Elias.

  Ver listado completo de autores

  Referencia: Blood 2020.

• IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

  Autores:

  Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S;

  (...)

  Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.

  Ver listado completo de autores

  Referencia: Nature Communications 2020.

• CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma

  Autores:

  Martin-Garcia, David; Navarro, Alba; Valdes-Mas, Rafael; Clot, Guillem; Gutierrez-Abril, Jesus;

  (...)

  Lopez-Otin, Carlos; Salaverria, Itziar; Puente, Xose S; Campo, Elias; Bea, Silvia.

  Ver listado completo de autores

  Referencia: Blood 2019.

• A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

  Autores:

  Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina;

  (...)

  Rosenwald, Andreas; Scott, David W; Rimsza, Lisa M; Bea, Silvia; Campo, Elias.

  Ver listado completo de autores

  Referencia: Blood 2018.

• Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

  Autores:

  Karube, K; Enjuanes, A; Dlouhy, I; Jares, P; Martin-Garcia, D;

  (...)

  Schmitz, R; Staudt, L M; Salaverria, I; Lopez-Guillermo, A; Campo, E.

  Ver listado completo de autores

  Referencia: Leukemia 2018.

• Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

  Autores:

  Nadeu, F; Clot, G; Delgado, J; Martin-Garcia, D; Baumann, T;

  (...)

  Puente, X S; Lopez-Otin, C; Lopez-Guillermo, A; Enjuanes, A; Campo, E.

  Ver listado completo de autores

  Referencia: Leukemia 2018.

Proyectos destacados

• Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

  Investigador/a principal: Elías Campo Güerri

  Financiador: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

  Código: 1P01CA229100

  Duración: 01/09/2019 - 31/08/2024

• Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)

  Investigador/a principal: Elías Campo Güerri

  Financiador: European Commission

  Código: H2020-ERC-Sy_2018 (810287)

  Duración: 01/04/2019 - 31/03/2024

• CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention

  Investigador/a principal: Elías Campo Güerri

  Financiador: La Caixa Foundation

  Código: HR17-00221_ LCF/PR/HR17/52150017

  Duración: 31/12/2018 - 31/12/2022

• EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine

  Investigador/a principal: Elías Campo Güerri

  Financiador: European Commission

  Código: CE_H2020-SC1_18_1s 825835

  Duración: 01/01/2019 - 30/06/2023

• La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.

  Investigador/a principal: Elías Campo Güerri

  Financiador: Generalitat de Catalunya

  Código: SLT002/16/00374

  Duración: 27/03/2017 - 31/12/2023